The New England Journal of Medicine has published a clinical trial showing that Novartis' Ultibro Breezhaler outshone GlaxoSmithKline's Seretide on reducing COPD flare-ups, which could challenge the ...
Seretide/Advair is GSK’s best-selling drug, and the line was extended in 2003 when the European Union approved the higher-dose 500 Accuhaler for the symptomatic treatment of severe COPD, i.e., ...
GSK and Theravance announce positive results from studies comparing ANORO™ ELLIPTA™ with SERETIDE® DISKUS®and ADVAIR® DISKUS® in patients with COPD GlaxoSmithKline plc (LSE/NYSE: GSK) and Theravance, ...
A major pharmaceutical company which alleges trademark infringement has been refused an injunction preventing the roll-out by a rival of an inhaler for asthmatics. The injunction was sought pending ...
Mumbai: Glenmark Pharmaceuticals Ltd said on Friday that it has received regulatory approval for the generic version of GlaxoSmithKline Plc’s Seretide Accuhaler in the Nordic region, which includes ...
ASTHMA sufferers have been told to check their inhalers after two brands have issued an urgent recall. Here’s what you need to know to work out if you need to pass your puffer back. Two brands have ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results